% Expired Patents = 20.0

EPO Patents = 4

Forward Citations = 49

Loading Chart...

5 inventors (with patents filed for the assignee):

Stefanie Dimmeler (5 out of 12 patents)

Andreas Michael Zeiher (5 out of 11 patents)

Carmen Urbich (4 out of 4 patents)

4. Angelika Bonauer (4 out of 4 patents)

5. Christopher Heeschen (1 out of 14 patents)

6. Andreas Zeiher (0 patent)

7. Andreas M Zeiher (0 patent)

8. Christopher Heeschen (0 patent)

5 patents: Sort by Forward Citations

1. 9862949 - Method for the inhibition of angiogenesis (2018-01-09),

2. 9279123 - Method for promoting angiogenesis, vascularization or vessel repair or for inhibiting tumor angiogenesis (2016-03-08),

3. 8912158 - Method for treating myocardial infarct (2014-12-16),

4. 8258113 - Method for promoting angiogenesis, vascularization or vessel repair (2012-09-04),

5. 7919315 - In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (BMPS) and/or blood-derived circulating precursor cells (BDPS) (2011-04-05),

T2cure GmbH is a biotech company focused on developing innovative therapies for cardiovascular diseases. Our cutting-edge technology aims to revolutionize the treatment of heart disorders, providing patients with better outcomes and improved quality of life. With a team of experienced scientists and medical professionals, T2cure is dedicated to bringing groundbreaking solutions to the market and making a significant impact in the field of cardiology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

5 Patents

#97 in Frankfurt

#6,086 in Germany

Frankfurt, Germany

T2cure Gmbh